Tag: Newronika
Newronika closes €13.6 million funding round following US FDA approval for...
Newronika has successfully closed its €13.6 million Series B funding round led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation...
Newronika announces CE mark for AlphaDBS system
Newronika has announced the CE mark approval for its AlphaDBS system to treat Parkinson’s disease. According to a company press release, Newronika is a spin-off of the world-class neurological research centre Policlinico of Milan...
